Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disrup-tions and alterations of several molecular pathways that result in heterogeneous pheno-types and variable disease outcome. Combining this disparate knowledge may offer insights for deciphering relevant molecular processes regarding targeted therapeutic ap-proaches guided by molecular signatures allowing improved phenotype profiling. The aim of the study is to characterize muscle invasive bladder carcinoma on a molecular level by in-corporating scientific literature screening and signatures from omics profiling. Public domain omics signatures together with molecular features associated with muscle invasive bladder cancer were derived from literature minin...
Multi-omics signatures of patients with bladder cancer (BC) can guide the identification of known de...
Patients with advanced bladder cancer have poor outcomes, indicating a need for more efficient thera...
Despite advances in management, bladder cancer remains a major cause of cancer related complications...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
The best way to increase patient survival rate is to identify patients who are likely to progress to...
International audienceBackground: Molecular understanding of muscle-invasive (MIBC) and non–muscle-i...
Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence ...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
Full list of author information is available at the end of the articleClinically, bladder cancer pos...
We report a comprehensive analysis of 412 muscle-invasive bladder cancers characterized by multiple ...
<div><p>The effective detection and management of muscle-invasive bladder Transition Cell Carcinoma ...
This study aimed to detect protein changes that can assist to understand the underlying biology of b...
Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnos...
Multi-omics signatures of patients with bladder cancer (BC) can guide the identification of known de...
Patients with advanced bladder cancer have poor outcomes, indicating a need for more efficient thera...
Despite advances in management, bladder cancer remains a major cause of cancer related complications...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Muscle invasive bladder carcinoma is a complex, multifactorial disease caused by disruptions and alt...
Bladder cancer is the 10th most common cancer in the world [1]. It is the 6th most common amongst me...
The best way to increase patient survival rate is to identify patients who are likely to progress to...
International audienceBackground: Molecular understanding of muscle-invasive (MIBC) and non–muscle-i...
Patients with bladder cancer need frequent controls over long follow-up time due to high recurrence ...
INTRODUCTION: We previously identified common differentially expressed (DE) genes in bladder cancer ...
Full list of author information is available at the end of the articleClinically, bladder cancer pos...
We report a comprehensive analysis of 412 muscle-invasive bladder cancers characterized by multiple ...
<div><p>The effective detection and management of muscle-invasive bladder Transition Cell Carcinoma ...
This study aimed to detect protein changes that can assist to understand the underlying biology of b...
Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnos...
Multi-omics signatures of patients with bladder cancer (BC) can guide the identification of known de...
Patients with advanced bladder cancer have poor outcomes, indicating a need for more efficient thera...
Despite advances in management, bladder cancer remains a major cause of cancer related complications...